Sign In
Buy AZN
$183.02
+2.00 (+1.10%)
At Close: Jun 24, 2026
Mereo BioPharma (MREO) Up as AstraZeneca Reportedly Eyes Buyout
02:36pm, Monday, 20'th Jun 2022 Zacks Investment Research
Shares of Mereo BioPharma (MREO) surge after reports suggest that AstraZeneca (AZN) is interested in acquiring it.
Dow ends lower in mixed finish for U.S. stocks, S&P 500 suffers worst week since March 2020
11:24am, Saturday, 18'th Jun 2022 MarketWatch
U.S. stocks end mixed Friday, with all three major benchmarks closing a choppy session of trade with bruising weekly losses.
AstraZeneca weighs bid for Mereo, Carnival Cruises partners with MGM, Devon Energy stock plunges
04:20pm, Friday, 17'th Jun 2022
Yahoo Finance Live anchors Rachelle Akuffo, Seana Smith and Dave Briggs look at several of today's trending stocks tied to leading industry stories, including AstraZeneca weighing bid for Mereo, Carni
Valneva (VALN) Stock Declines 59% in 3 Months: Here's Why
02:14pm, Friday, 17'th Jun 2022 Zacks Investment Research
Though Valneva's (VALN) COVID-19 vaccine looks promising, the European Commission's intent to terminate the advance purchase agreement for the vaccine puts the future of the company's COVID-19 vaccine
AstraZeneca weighing bid for Mereo BioPharma: report
03:44am, Friday, 17'th Jun 2022
AstraZeneca AZN, +0.48% AZN, +0.42% is considering a bid for London-based, U.S.-listed biotech Mereo BioPharma MREO, +16.03% , The Times reported without attribution. AstraZeneca already is a partner
Astrazeneca (AZN) Gains As Market Dips: What You Should Know
10:15pm, Thursday, 16'th Jun 2022 Zacks Investment Research
Astrazeneca (AZN) closed the most recent trading day at $60.86, moving +0.48% from the previous trading session.
This Cancer Drug's News Could Mean Another Blockbuster for AstraZeneca
03:23pm, Tuesday, 14'th Jun 2022 The Motley Fool
AstraZeneca's already diverse business just got another boost.
This Cancer Drug's News Could Mean Another Blockbuster for AstraZeneca
11:23am, Tuesday, 14'th Jun 2022
AstraZeneca's already diverse business just got another boost.
AstraZeneca downgraded by UBS on lack of catalysts until 2023
07:26am, Tuesday, 14'th Jun 2022
AstraZeneca PLC (LSE:AZN) shares have been downgraded by UBS on the basis that there are “no major catalysts” in its drug pipeline for the rest of the year. The shares are currently trading on a s
Astrazeneca (AZN) Stock Moves -1.45%: What You Should Know
10:15pm, Friday, 10'th Jun 2022 Zacks Investment Research
In the latest trading session, Astrazeneca (AZN) closed at $61.79, marking a -1.45% move from the previous day.
What Could a Recession Mean for Healthcare Stocks?
03:30pm, Thursday, 09'th Jun 2022 The Motley Fool
It depends on which subsector you're talking about.
What Could a Recession Mean for Healthcare Stocks?
11:30am, Thursday, 09'th Jun 2022
It depends on which subsector you're talking about.
Emergent (EBS) Stock Down as J&J Ends COVID-19 CDMO Contract
01:07pm, Tuesday, 07'th Jun 2022 Zacks Investment Research
Emergent (EBS) sends contract breach notice to J&J, following the latter's decision to end their contract for CDMO services for its COVID-19 vaccine. J&J also cites contract breach as the basis for te
Nasdaq Bear Market: 3 of the Safest Stocks on the Planet to Buy Right Now
09:06am, Tuesday, 07'th Jun 2022 The Motley Fool
An up to 31% plunge in the Nasdaq is the perfect excuse to put your money to work in these three steady businesses.
Nasdaq Bear Market: 3 of the Safest Stocks on the Planet to Buy Right Now
05:06am, Tuesday, 07'th Jun 2022
An up to 31% plunge in the Nasdaq is the perfect excuse to put your money to work in these three steady businesses.
